Shares of Medtronic PLC (NYSE:MDT) have been assigned an average rating of “Hold” from the twenty-five analysts that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, ten have given a hold recommendation, twelve have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $88.73.

MDT has been the subject of several recent research reports. Evercore ISI lifted their target price on shares of Medtronic PLC from $88.00 to $88.50 and gave the company an “outperform” rating in a report on Wednesday, April 19th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $85.00 target price on shares of Medtronic PLC in a report on Tuesday, April 18th. Needham & Company LLC reaffirmed a “buy” rating and set a $91.00 target price on shares of Medtronic PLC in a report on Monday, March 27th. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Medtronic PLC in a report on Tuesday, May 16th. They set a “neutral” rating and a $87.00 target price for the company. Finally, Vetr lowered shares of Medtronic PLC from a “hold” rating to a “sell” rating and set a $78.50 target price for the company. in a report on Wednesday, March 1st.

Shares of Medtronic PLC (MDT) traded up 1.03% during mid-day trading on Monday, reaching $88.99. 3,806,584 shares of the company traded hands. Medtronic PLC has a 52 week low of $69.35 and a 52 week high of $89.27. The firm has a 50-day moving average price of $84.84 and a 200 day moving average price of $79.22. The firm has a market capitalization of $121.83 billion, a price-to-earnings ratio of 30.79 and a beta of 1.04.

Medtronic PLC (NYSE:MDT) last posted its earnings results on Thursday, May 25th. The medical technology company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.02. The firm had revenue of $7.92 billion during the quarter, compared to analyst estimates of $7.86 billion. Medtronic PLC had a net margin of 13.56% and a return on equity of 12.72%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.27 EPS. On average, analysts anticipate that Medtronic PLC will post $4.95 earnings per share for the current year.

A number of large investors have recently made changes to their positions in the company. Gould Asset Management LLC CA boosted its stake in shares of Medtronic PLC by 2.0% in the fourth quarter. Gould Asset Management LLC CA now owns 10,449 shares of the medical technology company’s stock valued at $744,000 after buying an additional 204 shares during the period. Equity Investment Corp Acquisition Inc acquired a new stake in shares of Medtronic PLC during the fourth quarter valued at about $98,289,000. Motley Fool Wealth Management LLC boosted its stake in shares of Medtronic PLC by 1.7% in the fourth quarter. Motley Fool Wealth Management LLC now owns 98,910 shares of the medical technology company’s stock valued at $7,045,000 after buying an additional 1,637 shares during the period. Alley Co LLC boosted its stake in shares of Medtronic PLC by 0.4% in the fourth quarter. Alley Co LLC now owns 47,801 shares of the medical technology company’s stock valued at $3,405,000 after buying an additional 207 shares during the period. Finally, Johnson Financial Group Inc. boosted its stake in shares of Medtronic PLC by 28.6% in the fourth quarter. Johnson Financial Group Inc. now owns 7,287 shares of the medical technology company’s stock valued at $519,000 after buying an additional 1,620 shares during the period. 82.48% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.americanbankingnews.com/2017/06/19/medtronic-plc-mdt-given-consensus-rating-of-hold-by-brokerages.html.

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.